Alembic Pharmaceuticals Ltd Quarterly Results

Gross Sales

1,910.15

1,710.72

1,769.64

1,692.74

1,647.98

Excise Duty

0

0

0

0

0

Net Sales

1,910.15

1,710.72

1,769.64

1,692.74

1,647.98

Other Operating Income

0

0

0

0

0

Other Income

8.33

6.5

14.19

9.86

30.47

Total Income

1,918.48

1,717.22

1,783.83

1,702.6

1,678.45

Total Expenditure

1,594.46

1,429.82

1,498.38

1,432.52

1,408.71

PBIDT

324.02

287.4

285.45

270.08

269.74

Interest

24.23

23.52

24.52

22.26

18.81

PBDT

299.79

263.88

260.93

247.82

250.93

Depreciation

76.07

73.77

68.99

70.04

70.51

Minority Interest Before NP

0

0

0

0

0

Tax

46.59

22.22

20.64

22.48

40.23

Deferred Tax

-6.58

14.26

14.67

17.6

-12.95

Reported Profit After Tax

183.71

153.63

156.63

137.7

153.14

Minority Interest After NP

-1

-0.75

-0.26

-0.72

-0.27

Net Profit after Minority Interest

184.71

154.38

156.89

138.42

153.41

Extra-ordinary Items

0

0

0

0

10

Adjusted Profit After Extra-ordinary item

184.71

154.38

156.89

138.42

143.41

EPS (Unit Curr.)

9.4

7.85

7.98

7.01

7.79

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

39.31

39.31

39.31

39.31

39.31

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.96

16.79

16.13

15.95

16.36

PBDTM(%)

15.69

15.42

14.74

14.64

15.22

PATM(%)

9.61

8.98

8.85

8.13

9.29